Arthritis & Rheumatology: "Mid-Term" Report

Affiliations

¹ Brigham and Women's Hospital, Boston, Massachusetts.
² Yale School of Medicine, New Haven, Connecticut.
³ National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
⁴ Brigham and Women's Hospital and Boston Children's Hospital, Boston, Massachusetts.

Editorial

Daniel H Solomon et al. Arthritis Rheumatol. 2022 Jul.

. 2022 Jul;74(7):1099-1101.

doi: 10.1002/art.42131. Epub 2022 May 6.

¹ Brigham and Women's Hospital, Boston, Massachusetts.
² Yale School of Medicine, New Haven, Connecticut.
³ National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
⁴ Brigham and Women's Hospital and Boston Children's Hospital, Boston, Massachusetts.

No abstract available

References

1. Tu JF, Yang JW, Shi GX, Yu ZS, Li JL, Lin LL, et al. Efficacy of intensive acupuncture versus sham acupuncture in knee osteoarthritis: a randomized controlled trial. Arthritis Rheumatol 2021;73:448-58.
1. Isenberg D, Furie R, Jones NS, Guibord P, Galanter J, Lee C, et al. Efficacy, safety, and pharmacodynamic effects of the Bruton's tyrosine kinase inhibitor fenebrutinib (GDC-0853) in systemic lupus erythematosus: results of a phase II, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 2021;73:1835-46.
1. Coates LC, Pillai SG, Tahir H, Valter I, Chandran V, Kameda H, et al. Withdrawing ixekizumab in patients with psoriatic arthritis who achieved minimal disease activity: results from a randomized, double-blind withdrawal study. Arthritis Rheumatol 2021;73:1663-72.
1. Gaffo AL, Calhoun DA, Rahn EJ, Oparil S, Li P, Dudenbostel T, et al. Effect of serum urate lowering with allopurinol on blood pressure in young adults: a randomized, controlled, crossover trial. Arthritis Rheumatol 2021;73:1514-22.
1. Khanna PP, Khanna D, Cutter G, Foster J, Melnick J, Jaafar S, et al. Reducing immunogenicity of pegloticase with concomitant use of mycophenolate mofetil in patients with refractory gout: a phase II, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 2021;73:1523-32.